IQE Emerges from Strategic Review with MACOM Lifeline, Targets 20%-Plus Revenue Growth on Indium Phosphide Surge
Full-Year 2025 Earnings Call, May 28, 2026 — IQE plc (IQE.L)
IQE's 2025 full-year results presentation was less about the numbers — which were frankly disappointing — and more about the close of an existential chapter. The compound semiconductor wafer specialist confirmed the completion of an £81 million fundraise anchored by U.S.-based MACOM Technology Solutions, clearing its bank debt and ending an 18-month strategic review that had effectively placed a gag order on management communications with the market. New CEO Jutta Meier used the occasion to lay out a forward-looking case built on indium phosphide demand from AI data centers, a recovering wireless market, and what she described as a fundamentally transformed balance sheet. The question now is whether the operational leverage embedded in IQE's largely fixed-cost structure will translate into the margin recovery the company is projecting.
A Year Best Forgotten, With a Second Half That Offers Some Hope
Group revenue for 2025 came in at £97.3 million, split between a Photonics segment that grew 15% to £57.1 million and a Wireless segment that collapsed 40% to £40.1 million. The wireless decline was the dominant story of the first half, driven by a combination of global macroeconomic uncertainty tied to tariff disruption, customer inventory builds in mobile handsets, and delayed U.S. military and defense budget releases. Adjusted EBITDA landed at just £3.2 million, a number Meier attributed directly to low utilization of IQE's manufacturing footprint rather than any structural deterioration in the business. The company ended 2025 with cash of £15.7 million and adjusted net debt of £31.5 million — a position that, prior to the MACOM deal, raised legitimate questions about IQE's financial runway.
The second half told a more encouraging story. Wireless customer inventories depleted, U.S. defense budgets were released, and AI-driven demand for indium phosphide photonic products accelerated. Meier was careful to frame this recovery as durable rather than cyclical: "These issues eased in the second half of the year. By the end of the year, we saw significant improvements, which have continued into 2026." The working capital inflow of £11.2 million also helped adjusted operating cash flow improve meaningfully year-on-year.
The MACOM Deal: Debt Cleared, Independence Preserved, but Questions on Control Remain
The £81 million fundraise is the most consequential development in IQE's recent history. MACOM contributed £45 million — £30 million in cash and £15 million in convertible loan notes — with the remainder coming from existing shareholders. The proceeds retire the HSBC revolving credit facility in full, leaving IQE with no bank debt and net cash inflows post-repayment of approximately £27.9 million. Alongside the capital injection, IQE has signed long-term strategic supply agreements with MACOM, providing what Meier described as "revenue visibility and stability."
The governance implications are significant. MACOM's COO Robert Dennehy and VP David O'Carroll are being nominated as Non-Executive Directors, subject to Nomad due diligence. When asked directly by Deutsche Bank analyst John Karidis whether a standstill agreement exists preventing MACOM from increasing its stake further, Meier confirmed there is none: "If MACOM wants to increase their position within IQE, they can do so via just the usual tools that are available. There's nothing that would prevent them to do that." That answer will matter to shareholders who want to understand the long-term ownership trajectory of the business, particularly given that a full sale of the company was explicitly evaluated during the strategic review.
Meier acknowledged as much when asked about IQE's independence: "We went through a very detailed strategic review in which we checked and went through an assessment of a multitude of different models, obviously starting from the sale of Taiwan to also a complete sale of the company. And ultimately, staying independent is the best solution for IQE, and also creates the best value for our shareholders." The door is not closed; it is simply not open today.
Indium Phosphide Is the Core Growth Thesis — and a Supply Risk
The most commercially urgent topic of the call was indium phosphide, the material underpinning high-speed optical interconnects in AI data centers. Meier was explicit that this is not a future opportunity but a present one: "The nature of the supply they are demanding is very much in the here and now. This is a live market opportunity." IQE's decades of manufacturing experience in indium phosphide wafers, combined with its multi-site global footprint, position it as one of the very few credible suppliers at scale. The company also noted it has the ability to convert existing gallium arsenide tooling to support indium phosphide production, though any such conversion would need to be tied to firm customer commitments and would involve tool downtime and capital expenditure.
However, indium phosphide is not without risk. When asked directly about reported supply shortages of the raw material, Meier confirmed the company is actively managing the issue: "Indium phosphide is a very sought-after commodity these days. We are working closely with our suppliers to mitigate any kind of indium phosphide shortages... The main component here will be to dual source or to increase really our sourcing capabilities." This is a real near-term operational risk that investors should monitor, particularly given the second-half weighting of IQE's revenue outlook.
2026 Guidance: 20%-Plus Revenue Growth, High Single to Low Double-Digit EBITDA
Management guided for full-year 2026 revenue growth exceeding 20% year-on-year, which would put revenues above £116 million at a minimum. The company expects adjusted EBITDA to reach a high single-digit to low double-digit percentage of revenue — a substantial improvement from the near-breakeven 2025 result. The key mechanism here is operating leverage: IQE's fixed cost base, which crushed margins when volumes were low, becomes a powerful earnings amplifier as utilization rises. Meier was direct on this point: "Any kind of volume increases fall through significantly on the bottom line."
Q1 2026 trading was described as in line with management expectations, with particular strength in indium phosphide photonics for AI and data centers, VCSEL and wireless products for consumer smartphones, and continued aerospace and defense demand. The company indicated strong order book visibility into the second half. Karidis pressed on whether MACOM's long-term agreement was the primary driver of the growth guidance, and Meier declined to quantify the contribution but confirmed it is a driver while emphasizing diversification: "We are working on multiple fronts and not just relying on a sort of just one player alone, because we also need to mitigate our exposure to market fluctuations."
Capital Expenditure Discipline and the Customer Co-Funding Model
CapEx declined from £11 million in 2024 to £6 million in 2025, and management guided that 2026 spending will remain limited to maintenance CapEx only. Any capacity expansion — including additional MOCVD reactors — will require customer commitments and potentially customer co-funding or tool consignment arrangements. Meier outlined a range of commercial structures: "It can be done via an LTA. It can be done via co-funding. It can even be handled through a consignment of tools." This approach protects IQE's cash position but places the onus on customers to signal demand concretely before capacity is added. It also means IQE is unlikely to get ahead of demand in the way that could cause future utilization problems — a lesson perhaps learned from painful experience.
On the question of CHIPS Act funding in the United States, Meier confirmed IQE is still engaged with government counterparts: "We are still and have been engaging with governments in general on funding opportunities. I think our situation now is a completely different position to have when it comes to these negotiations." The improved balance sheet and the MACOM partnership presumably strengthen that case, though no specific application or timeline was disclosed.
Wireless Recovery Has More Legs, MicroLED Remains a Future Story
The wireless segment's 40% revenue decline in 2025 was painful, but management argued the recovery is not purely inventory-driven. Meier cited new design wins alongside market normalization: "This has also been coupled with new design wins that we've seen and we've been able to realize across new technologies in the wireless segment." Whether this constitutes a structural improvement or a cyclical bounce remains to be demonstrated over the next several quarters.
On microLED, Meier described it as "a significant growth driver" for the future and noted "significant traction with various partners," but declined to provide revenue timelines or any quantification of contribution. For now, microLED remains a technology development story with commercial revenues that are not yet material enough to disclose. The 6-inch to 8-inch wafer transition question received a similarly non-committal answer — any diameter transition is customer-demand-driven, and IQE is not pushing the market in any particular direction independently.
A New CEO, a New Chapter — Execution Is Now the Only Question
Meier, who spent over 25 years in the semiconductor industry primarily in Silicon Valley before joining IQE, was careful to distinguish between the company's strategic positioning and its recent financial performance. The two have been sharply disconnected — IQE operates at the intersection of compound semiconductors, AI infrastructure, defense technology, and advanced photonics, yet delivered near-zero EBITDA in 2025. The argument is that the fixed cost base, the prolonged strategic review, and cyclical headwinds in wireless combined to produce a misleading picture of underlying earnings power. That argument will be tested in 2026. The company has the technology portfolio, the customer relationships, the global manufacturing footprint, and now the balance sheet to compete. The 2025 results confirm it has not yet translated those assets into financial returns at scale.
IQE plc Deep Dive
The Epitaxial Engine at the Heart of the AI and RF Cycle
In the semiconductor value chain, epitaxial wafer manufacturing is an esoteric, capital-intensive niche that commands outsized strategic importance. IQE plc is the world’s largest merchant foundry for compound semiconductor epi-wafers, controlling roughly 50% of the global outsourced market for wireless gallium arsenide substrates. Unlike traditional silicon foundries that fabricate actual chip circuitry, IQE’s business model is fundamentally materials science: the company engineers complex, atomic-level crystalline layers on base substrates. These engineered wafers are then sold to integrated device manufacturers and fabless companies who etch and dice them into the specialized chips that power everything from 5G handsets and advanced military radar to the optical interconnects inside hyperscale artificial intelligence data centers.
The company’s portfolio spans Gallium Arsenide, Gallium Nitride, Indium Phosphide, and advanced Silicon Germanium. IQE acts as the invisible substrate foundation for a broad swath of the global technology ecosystem. Its key customers include the dominant RF front-end module makers, such as Broadcom, Skyworks, and Qorvo, as well as leading optoelectronics players like Lumentum, which in turn feeds the Apple supply chain for 3D sensing, FaceID, and augmented reality hardware. Furthermore, a recently deepened strategic relationship with MACOM Technology Solutions underlines IQE’s pivotal position in both defense and telecommunications infrastructure.
Market Share, Competitors, and the Merchant Foundry Dynamic
The market for compound semiconductors is highly consolidated, characterized by steep barriers to entry. Crystal-growth know-how requires decades of proprietary metallurgical fine-tuning, and customer qualification cycles can last years. IQE sits at the apex of the merchant market with its dominant share in wireless gallium arsenide epi-wafers. However, the competitive landscape is divided between pure-play merchant suppliers and vertically integrated giants. In the merchant space, IQE competes fiercely with Taiwan’s Visual Photonics Epitaxy Co. and IntelliEPI in the United States. In the broader substrate market, integrated heavyweights like Japan’s Sumitomo Electric Industries maintain massive internal epi-wafer capacities, capturing premium market segments, while China’s Century Epitech and PAM Xiamen are rapidly scaling domestic 6-inch lines under state-sponsored semiconductor initiatives to capture local market share.
IQE’s scale has historically allowed it to absorb the massive capital expenditures required to deploy dozens of advanced reactors globally. However, scale is a double-edged sword. A high fixed-cost base means margins are hypersensitive to volume fluctuations. This was painfully evident during the recent handset inventory digestion cycle, which severely depressed profitability, but it also creates immense operational leverage when end-market volumes return.
Competitive Moats: Deep Tech and Defensive IP
IQE’s competitive advantage stems not just from sheer manufacturing scale, but from a deeply entrenched intellectual property portfolio and a global manufacturing footprint that shields Western customers from geopolitical supply chain shocks. The company’s crystalline rare-earth oxide technology is a standout innovation. By allowing compound semiconductors to be integrated directly onto standard silicon wafers, this technology provides low-resistance buried electrodes critical for high-efficiency RF filters. This capability bridges the performance gap between exotic compound materials and the economics of high-volume silicon manufacturing.
Additionally, IQE’s defense footprint in both the United Kingdom, via its Newport mega-foundry, and the United States ensures it remains a critical supplier of export-controlled gallium nitride on silicon carbide epi-wafers. These materials are the non-negotiable bedrock for modern electronic warfare systems, phased-array radars, and secure satellite communications. Defense revenues provide a sticky, high-margin counterweight to the inherent volatility of consumer smartphone cycles.
Industry Dynamics: The Photonics AI Boom and Wireless Volatility
The overarching narrative for IQE is a tale of two divergent end-markets. Over the last 2 years, the company’s Wireless division suffered heavily from a macroeconomic slowdown and inventory bloat in the mobile handset market, resulting in a 40% revenue drop in 2025. Yet, as the 5G upgrade cycle matures and early 6G infrastructure buildouts gather pace, RF front-end module volumes are structurally rebounding.
The true growth vector, however, is the explosive deployment of AI data centers. The transition to generative AI architectures requires immense data transfer rates between GPUs, necessitating 800G and 1.6T optical transceivers. Traditional copper interconnects cannot handle these speeds without catastrophic signal loss and heat generation. Indium Phosphide is the critical material enabling these high-speed, energy-efficient optical communication systems. IQE’s Photonics division is a direct beneficiary of this transition, with accelerated demand for Indium Phosphide solutions acting as the primary revenue driver for 2026 and beyond. A credible threat to this thesis is the rapid development of silicon photonics, a disruptive technology utilizing standard silicon to transmit light. However, even within silicon photonics packages, an Indium Phosphide light source is almost always still required, mitigating the risk of total obsolescence and actually expanding IQE's total addressable market as hybrid platforms proliferate.
Future Growth Drivers: MicroLEDs and GaN Power
Looking past the immediate AI tailwinds, IQE is incubating several disruptive technologies that can become meaningful growth drivers. The company is securing development orders for ultra-fast gallium nitride on silicon microLED solutions. These microscopic light emitters are viewed as the endgame for next-generation augmented and virtual reality displays, offering unmatched brightness and efficiency compared to current organic LED technology. By leveraging 8-inch manufacturing platforms, IQE is positioning itself to capture value early in the nascent smart glasses market.
Simultaneously, IQE is executing a diversification strategy into power electronics, targeting the electric vehicle and high-power charging markets. To fund this specific initiative without diluting the parent company, management is currently navigating a planned initial public offering of its Taiwanese operating subsidiary on the Taiwan Stock Exchange. This dual-track approach allows IQE to monetize localized assets while retaining control and participating in the upside of the Asian power electronics market.
Management Track Record: A Clinical Restructuring
The past 2 years have been a crucible for IQE’s management. Following a period of strategic drift, former CEO Americo Lemos departed in late 2024, paving the way for CFO Jutta Meier to step up as interim CEO. Alongside Executive Chair Mark Cubitt, the new leadership team enacted a ruthless but necessary turnaround. They shuttered underperforming legacy sites in Pennsylvania, consolidated the UK’s South Wales silicon operations into the flagship Newport facility, and relentlessly slashed operating costs to lower the breakeven point.
The culmination of this restructuring was the May 2026 conclusion of a strategic review, which resulted in a transformative £81 million fundraise. This capital injection completely eliminated the company’s bank debt and fortified the balance sheet. Crucially, the fundraise was anchored by a £45 million strategic investment from MACOM Technology Solutions, a major US semiconductor customer. MACOM’s willingness to take an 11.5% equity stake and inject zero-coupon convertible debt serves as an institutional validation of IQE’s technology and operational turnaround. With the balance sheet de-risked and a leaner manufacturing footprint, management has guided for greater than 20% revenue growth for the full year 2026, accompanied by a return to healthy adjusted EBITDA margins.
The Scorecard
IQE represents a high-leverage play on the foundational materials required for the world’s most advanced hardware megatrends, from AI optical interconnects to next-generation RF networks. The company has survived a brutal handset inventory downcycle and emerged with a vastly improved capital structure, a rationalized manufacturing footprint, and a highly credible strategic partner. The shift in revenue mix toward high-margin Indium Phosphide photonics and defense applications provides a structural uplift to profitability that highlights the intrinsic value of its complex intellectual property.
However, the structural realities of the merchant epi-wafer model remain. It is a highly capital-intensive business heavily dependent on the ultimate end-market success of a concentrated group of module makers. Management must skillfully navigate the threat of Chinese domestic substitution at the lower end of the technology curve and the persistent execution risks associated with scaling unproven microLED production. Nevertheless, with capacity utilization climbing and the AI-driven photonics super-cycle in full swing, the foundational physics of IQE’s business model are increasingly aligned with the trajectory of global computing infrastructure.